Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients
Purpose
This study will evaluate the role of using electronic sensors for asthma inhaler devices in monitoring medication adherence and asthma control
Condition
- Asthma
Eligibility
- Eligible Ages
- Over 5 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Adults (>18 years) and children (5-11 years old) with a clinical history (i.e. physician-diagnosed) of asthma - Moderate to severe asthmatics with ≥1 asthma-related ED visits or hospitalizations in the past year - Use of daily controller inhaler medications - Adult non-smokers, or lifetime use <5 pack years with no smoking in last 1 yr - Smartphone required - English or Spanish speaking
Exclusion Criteria
- No smartphone - Use of oral corticosteroids in prior 4 weeks - Pregnancy - Psychiatric conditions
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Health Services Research
- Masking
- Single (Outcomes Assessor)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Electronic sensor and OW education |
MDI sensor-generated alerts will be relayed and responded to (e.g. outreach worker contacts the participant for a missed dose) in real-time to the intervention group. Outreach worker will also assess intervention group participants' need for further asthma education and provide asthma education over the phone |
|
|
No Intervention Usual Care |
Usual care group will receive the electronic tracker but the sensor-generated alerts will not be delivered. If the usual care group rescue inhaler data reveals frequent use of rescue medication (daily use for >3 days) investigators will reach out (via app or phone call) to advise the participant to see their physician |
|
More Details
- Status
- Completed
- Sponsor
- Montefiore Medical Center
Study Contact
Detailed Description
This study will assess the feasibility of using electronic sensors for asthma inhalers in a population of urban minority adults and children with moderate-severe asthma in the Bronx. Investigators will also assess differences in asthma outcomes (specifically asthma control as a primary outcome measure) and treatment adherence in a group of participants with moderate-severe asthma who use inhalers with electronic sensors and real-time remote outreach worker monitoring/feedback compared to a group of participants who use inhalers with electronic sensors but without real-time monitoring/feedback.